4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000102
Options or other derivatives
- Director acquired 4,411 shares (grant or award)
- Director returned 15,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hirth Peter Director | 2024-02-27 | Returned to the company · Stock Option (Right to Buy) | −15,000 | 0 | D | ||
| Hirth Peter Director | 2024-02-28 | Grant or award · Stock Option (Right to Buy) | +4,411 | 4,411 | D | ||
Loading xslF345X05/form4.xml…